SITE MAP   |   CAREERS   |   CONTACT   |   
What we do

Zalicus is focused on discovering and developing novel-target pain therapies. Our internal pipeline includes Z944, a T-type calcium channel modulator for chronic and acute inflammatory pain, and modulator of the NaV 1.7 channel for chronic or acute pain. Learn More

Who we are

Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, revenue-generating collaborations and financial resources provide a solid foundation for success. Learn More

News and events      Get RSS (What's this?)


Zalicus and Epirus Announce Merger Agreement More



Zalicus to Present at AACR 2014 Annual Meeting More



Zalicus Reports Financial Results for the Fourth Quarter and Year-End 2013 More